Inactive Instrument

Ardea Biosciences, Inc. Stock

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

2012	SANOFI : AstraZeneca hungry to refill medicine cabinet	RE
2012	SANOFI : GSK goes hostile with $2.6 billion Human Genome offer	RE

SANOFI : AstraZeneca hungry to refill medicine cabinet	12-06-30	RE
SANOFI : GSK goes hostile with $2.6 billion Human Genome offer	12-05-09	RE
Ardea Biosciences, Inc. : Biotech targets fight back as Big Pharma circles	12-05-02	RE
Ardea Biosciences, Inc. : Warner Chilcott to explore sale of company	12-04-30	RE
SANOFI : AstraZeneca CEO quits as drug sales tumble	12-04-26	RE
Ardea Biosciences, Inc. : Watson to buy Actavis for at least $5.6 billion	12-04-25	RE

Ardea Biosciences, Inc. : Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Ardea Biosciences, Inc.	12-05-01	PR
Ardea Biosciences, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of Ardea Biosciences, Inc.	12-04-28	BU
Ardea Biosciences, Inc. : Law Office of Brodsky & Smith, LLC Announces Investigation of Ardea Biosciences, Inc.	12-04-24	PR
Ardea Biosciences, Inc. : Board of Directors Under Investigation for Potential Breaches of Fiduciary Duty by Law Offices of Howard G. Smith	12-04-24	BU
Ardea Biosciences, Inc. : Ryan & Maniskas, LLP Announces Investigation of Ardea Biosciences, Inc.	12-04-24	BU

Sector

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	-3.39%	102B
REGENERON PHARMACEUTICALS, INC.	+2.61%	96.09B
ARGENX SE	-1.02%	22.05B
BIONTECH SE	-18.14%	20.81B
GENMAB A/S	-6.87%	19.06B
WUXI APPTEC CO., LTD.	-40.70%	16.05B
BEIGENE, LTD.	-26.89%	14.01B
NEUROCRINE BIOSCIENCES, INC.	+1.12%	13.38B
SAREPTA THERAPEUTICS, INC.	+22.25%	11.01B